Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_1
1
20%
Ph not_applicable
4
80%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (20.0%)
N/A4 (80.0%)

Trials by Status

recruiting120%
completed480%

Recent Activity

1 active trials
Showing 5 of 5
recruitingnot_applicable

Comprehensive Behavioral Intervention for Tics

NCT05370391
completednot_applicable

Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics

NCT04578912
completednot_applicable

Psychosocial Intervention for Young Children With Chronic Tics

NCT03042507
completednot_applicable

Neurocognitive Correlates of Behavioral Treatment for Childhood Tic Disorders

NCT00675675
completedphase_1

Developing Cognitive Training for Tourette Syndrome

NCT01440023

Clinical Trials (5)

Showing 5 of 5 trials
NCT05370391Not Applicable

Comprehensive Behavioral Intervention for Tics

Recruiting
NCT04578912Not Applicable

Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics

Completed
NCT03042507Not Applicable

Psychosocial Intervention for Young Children With Chronic Tics

Completed
NCT00675675Not Applicable

Neurocognitive Correlates of Behavioral Treatment for Childhood Tic Disorders

Completed
NCT01440023Phase 1

Developing Cognitive Training for Tourette Syndrome

Completed

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5